Medical management of children with epilepsy

S Ackermann1, J M Wilmshurst

  • 1Department of Paediatric Neurology, Department of Paediatrics and Child Health Red Cross War Memorial Children's Hospital University of Cape Town, Rondebosch, Cape Town, South Africa - jo.wilmshurst@uct.ac.za.

Minerva Pediatrica
|October 22, 2014
PubMed

Insights

Pediatric epilepsy diagnosis is challenging due to varied presentations and seizure mimics. Holistic management requires addressing neurobehavioral comorbidities and tailoring treatments, with specialist referral advised for complex cases.

Area of Science:

  • Pediatric Neurology
  • Clinical Neuroscience

Background:

  • Epilepsy is a common, heterogeneous neurological disorder in children, presenting diagnostic challenges.
  • Seizure mimics and varied etiologies complicate accurate diagnosis and management.
  • Advances in neuroimaging and genetics have improved understanding of epilepsy's neuropathology.

Purpose of the Study:

  • To highlight the complexities in diagnosing and managing pediatric epilepsy.
  • To emphasize the importance of tailored treatment and holistic care.
  • To underscore the need for specialist referral in uncertain or refractory cases.

Main Methods:

  • Review of current understanding of pediatric epilepsy presentation and diagnosis.
  • Discussion of diagnostic challenges including seizure mimics and differential diagnoses.
  • Analysis of evolving treatment options and the need for evidence-based pediatric guidelines.

Main Results:

  • Epilepsy exhibits significant variability in presentation, etiology, and outcomes.
  • High prevalence of unrecognized neurobehavioral and psychiatric comorbidities (up to 80%).
  • Limited high-quality evidence for pediatric epilepsy treatments necessitates individualized approaches.

Conclusions:

  • Accurate diagnosis of pediatric epilepsy requires careful consideration of diverse presentations and mimics.
  • Comprehensive management must include screening for neurobehavioral/psychiatric issues and addressing psychosocial needs.
  • Early specialist consultation is crucial for diagnostic uncertainty and treatment resistance in pediatric epilepsy.

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.6K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
17